|

Ivonescimab Combined With Chemotherapy Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Ruijin Hospital1
  • Guangdong Provincial People's Hospital1

Indications

  • Lung Cancer2
  • Cancer2
  • KRAS G12C Lung Cancer1
  • Malignant Pleural Mesothelioma, Advanced1
  • Lung Cancer (NSCLC)1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.